Literature DB >> 50369

Cytoplasmic immunofluorescence of bone marrow plasma cells producing immunoglobulins of the four IgG subclasses.

A Morell, F Skvaril, W Hijmans, R Scherz.   

Abstract

Immunofluorescence studies were performed on bone marrow samples from 21 individuals with normal or slightly elevated serum IgG levels. On the average, 40.7 percent of the IgG-positive plasma cells contained molecules of the subclass IgG; 30.6 percent had intracellular IgG2; 21.7 percent, IgG3, and 7.0 percent, IgG4. These figures were compared to the relative serum IgG subclass concentrations. The principal finding was the discrepancy between the high relative number of IgG-3 producing bone marrow plasma cells and the low relative IgG3-producing bone marrow plasma cells and the low relative IgG3 serum concentration (5.5 percent of the total IgG). It was explained by the short biologic half-life of molecules of this subclass.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 50369

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  4 in total

1.  Studies on the origin of the precursor cells in multiple myeloma, Waldenström's macroglobulinaemia and benign monoclonal gammopathy. I. Cytoplasmic isotype and idiotype distribution in peripheral blood and bone marrow.

Authors:  B Van Camp; P Reynaert; L Broodtaerts
Journal:  Clin Exp Immunol       Date:  1981-04       Impact factor: 4.330

2.  Intracellular immunoglobulin distribution of bone marrow plasma cells as a diagnostic aid for primary amyloidosis.

Authors:  C Thielemans; W Aelbrecht; D Verbeelen; G Somers; M De Waele; B Van Camp
Journal:  J Clin Pathol       Date:  1982-03       Impact factor: 3.411

Review 3.  The bone marrow: the major source of serum immunoglobulins, but still a neglected site of antibody formation.

Authors:  R Benner; W Hijmans; J J Haaijman
Journal:  Clin Exp Immunol       Date:  1981-10       Impact factor: 4.330

4.  Development of anti-polysaccharide antibodies in asplenic children.

Authors:  L Hammarström; C I Smith
Journal:  Clin Exp Immunol       Date:  1986-11       Impact factor: 4.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.